Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway

[1]  Zhiyong Huang,et al.  Loss of N-cadherin is associated with loss of E-cadherin expression and poor outcomes of liver resection in hepatocellular carcinoma. , 2015, The Journal of surgical research.

[2]  Liwei Xie,et al.  The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells. , 2015, Gastroenterology.

[3]  C. Rangel-Escareño,et al.  PPARα via HNF4α regulates the expression of genes encoding hepatic amino acid catabolizing enzymes to maintain metabolic homeostasis , 2015, Genes & Nutrition.

[4]  Xiong Cai,et al.  Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma , 2014, Diagnostic Pathology.

[5]  G. Ning,et al.  Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis. , 2014, Journal of molecular endocrinology.

[6]  S. Bauersachs,et al.  Evidence for a role of E-cadherin in suppressing liver carcinogenesis in mice and men. , 2014, Carcinogenesis.

[7]  Wei Zheng,et al.  MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis , 2014, Medical Oncology.

[8]  S. Zhang,et al.  Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC , 2014, Medical Oncology.

[9]  W. Yeung,et al.  Perfluorooctanoate suppresses spheroid attachment on endometrial epithelial cells through peroxisome proliferator-activated receptor alpha and down-regulation of Wnt signaling. , 2013, Reproductive toxicology.

[10]  N. Kiyosawa,et al.  PPARα-mediated responses in human adult liver stem cells: In vivo/in vitro and cross-species comparisons , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  Kristen Jepsen,et al.  Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling , 2013, Cell.

[12]  Xiaoming Liu,et al.  MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3 , 2013, BMC Cancer.

[13]  A. Villanueva,et al.  Emerging Signaling Pathways in Hepatocellular Carcinoma , 2012, Liver Cancer.

[14]  Hsien-Da Huang,et al.  MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. , 2012, The Journal of clinical investigation.

[15]  Xing-Xing He,et al.  MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo , 2012, Oncogene.

[16]  A. Herling,et al.  AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats , 2012, Acta Pharmacologica Sinica.

[17]  Jian-Rong Yang,et al.  MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein , 2011, Nucleic acids research.

[18]  Kevin Struhl,et al.  An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis , 2011, Cell.

[19]  X. Bian,et al.  The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 , 2011, Gut.

[20]  Meng-chao Wu,et al.  Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines , 2011, BMC gastroenterology.

[21]  Derek Y. Chiang,et al.  MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. , 2011, Gastroenterology.

[22]  Hongbing Shen,et al.  A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinoma , 2011, International journal of cancer.

[23]  X. Chen,et al.  Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. , 2010, Cancer research.

[24]  Y. Jeng,et al.  Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. , 2010, Carcinogenesis.

[25]  Xiao‐hui Huang,et al.  MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell , 2010, Medical oncology.

[26]  Shinji Tanaka,et al.  miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. , 2010, Carcinogenesis.

[27]  C. Chi,et al.  PPARγ/PGC-1α Pathway in E-Cadherin Expression and Motility of HepG2 Cells , 2009 .

[28]  J. Yun,et al.  Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.

[29]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[30]  Jian-Rong Yang,et al.  MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. , 2009, Cancer research.

[31]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[32]  K. Mimori,et al.  The search for cancer stem cells in hepatocellular carcinoma. , 2008, Surgery.

[33]  Krista A. Zanetti,et al.  Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.

[34]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[35]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[36]  C. Croce,et al.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.

[37]  Derek Y. Chiang,et al.  Genomics and signaling pathways in hepatocellular carcinoma. , 2007, Seminars in liver disease.

[38]  M. Ikura,et al.  Solution structure of the epithelial cadherin domain responsible for selective cell adhesion , 1995, Science.

[39]  U. Plessmann,et al.  Amino acid sequence characterization of mammalian vimentin, the mesenchymal intermediate filament protein , 1983, FEBS letters.

[40]  T. W. Perry.  The Effect of Genetic Variance of Nutritional Requirement of Animals: Proceedings of a 1974 Symposium , 1976 .

[41]  D. Iliopoulos,et al.  Therapeutically targeting microRNAs in liver cancer. , 2013, Current pharmaceutical design.

[42]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[43]  C. Chi,et al.  PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells. , 2009, Anticancer research.

[44]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[45]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[46]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.